Hsing‐Yu Hsu

490 total citations
22 papers, 377 citations indexed

About

Hsing‐Yu Hsu is a scholar working on Molecular Biology, Plant Science and Immunology. According to data from OpenAlex, Hsing‐Yu Hsu has authored 22 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Plant Science and 4 papers in Immunology. Recurrent topics in Hsing‐Yu Hsu's work include Phytochemistry and biological activities of Ficus species (4 papers), interferon and immune responses (3 papers) and Phytoplasmas and Hemiptera pathogens (2 papers). Hsing‐Yu Hsu is often cited by papers focused on Phytochemistry and biological activities of Ficus species (4 papers), interferon and immune responses (3 papers) and Phytoplasmas and Hemiptera pathogens (2 papers). Hsing‐Yu Hsu collaborates with scholars based in Taiwan, United States and Japan. Hsing‐Yu Hsu's co-authors include Shiow‐Ju Lee, Cheng‐Wei Yang, Yue‐Zhi Lee, Yu‐Sheng Chao, Hsin-Yu Chang, Hsun‐Shuo Chang, Hwan‐You Chang, Ih‐Sheng Chen, Hwan‐You Chang and Chuan Shih and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Hsing‐Yu Hsu

20 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsing‐Yu Hsu Taiwan 12 198 89 65 41 36 22 377
Zhaohui Meng China 13 304 1.5× 48 0.5× 83 1.3× 46 1.1× 26 0.7× 36 538
Shabnam Malik India 13 198 1.0× 79 0.9× 29 0.4× 41 1.0× 37 1.0× 23 410
Vikash Singh India 16 472 2.4× 165 1.9× 77 1.2× 23 0.6× 31 0.9× 26 657
Olga I. Kiseleva Russia 9 272 1.4× 45 0.5× 42 0.6× 16 0.4× 23 0.6× 39 496
Mohadeseh Hasanpourghadi Malaysia 10 190 1.0× 49 0.6× 35 0.5× 32 0.8× 30 0.8× 20 383
Prashanth Srinivasan Canada 11 605 3.1× 135 1.5× 49 0.8× 16 0.4× 58 1.6× 15 760
Elaine Yue Ling Wong Hong Kong 13 255 1.3× 163 1.8× 63 1.0× 19 0.5× 35 1.0× 17 497
Chunwei Cheng China 15 299 1.5× 41 0.5× 59 0.9× 21 0.5× 38 1.1× 19 633
Weifan Jiang China 11 258 1.3× 34 0.4× 29 0.4× 21 0.5× 21 0.6× 34 441
Shuna Cui China 11 210 1.1× 38 0.4× 45 0.7× 39 1.0× 72 2.0× 25 420

Countries citing papers authored by Hsing‐Yu Hsu

Since Specialization
Citations

This map shows the geographic impact of Hsing‐Yu Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsing‐Yu Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsing‐Yu Hsu more than expected).

Fields of papers citing papers by Hsing‐Yu Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsing‐Yu Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsing‐Yu Hsu. The network helps show where Hsing‐Yu Hsu may publish in the future.

Co-authorship network of co-authors of Hsing‐Yu Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsing‐Yu Hsu. A scholar is included among the top collaborators of Hsing‐Yu Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsing‐Yu Hsu. Hsing‐Yu Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Hsing‐Yu, Shih‐Sheng Chang, Daniel Hsiang‐Te Tsai, et al.. (2025). Comparative Effectiveness of Clopidogrel vs . Potent P2Y 12 Inhibitors in CYP2C19 Normal Metabolizers Following Percutaneous Coronary Intervention: A Real‐World Cohort Study. British Journal of Clinical Pharmacology. 92(4). 1167–1176.
2.
Yang, Cheng‐Wei, Hsing‐Yu Hsu, Yue‐Zhi Lee, & Shiow‐Ju Lee. (2024). Vitamin B12 inhibits peptidylarginine deiminases and ameliorates rheumatoid arthritis in CAIA mice. Biochemical and Biophysical Research Communications. 704. 149668–149668. 5 indexed citations
3.
4.
Hsu, Hsing‐Yu, et al.. (2024). Increased risk of hearing loss associated with MT-RNR1 gene mutations: a real-world investigation among Han Taiwanese Population. BMC Medical Genomics. 17(1). 155–155. 1 indexed citations
5.
Liu, Ting‐Yuan, Hsing‐Yu Hsu, Ying‐Shu You, et al.. (2023). Efficacy of Warfarin Therapy Guided by Pharmacogenetics: A Real-world Investigation Among Han Taiwanese. Clinical Therapeutics. 45(7). 662–670. 8 indexed citations
6.
Yang, Cheng‐Wei, Hsing‐Yu Hsu, Yue‐Zhi Lee, et al.. (2023). Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin. Biochemical Pharmacology. 215. 115688–115688. 12 indexed citations
7.
Hsu, Hsing‐Yu, et al.. (2022). Knowledge Navigated Quantum-inspired Tabu Search Algorithm for Reversible Circuit Synthesis. 2022 IEEE International Conference on Systems, Man, and Cybernetics (SMC). 2135–2140. 5 indexed citations
8.
9.
Lee, Yue‐Zhi, Hsing‐Yu Hsu, Cheng‐Wei Yang, et al.. (2022). The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics. 14(7). 1511–1511. 1 indexed citations
10.
Yang, Cheng‐Wei, Hsing‐Yu Hsu, Hsin-Yu Chang, Yue‐Zhi Lee, & Shiow‐Ju Lee. (2020). Natural cardenolides suppress coronaviral replication by downregulating JAK1 via a Na+/K+-ATPase independent proteolysis. Biochemical Pharmacology. 180. 114122–114122. 15 indexed citations
11.
Yeh, Teng‐Kuang, Ching‐Chuan Kuo, Yue‐Zhi Lee, et al.. (2017). Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors. Journal of Medicinal Chemistry. 60(13). 5599–5612. 30 indexed citations
12.
Yang, Cheng‐Wei, Yue‐Zhi Lee, Hsing‐Yu Hsu, et al.. (2017). Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity. Scientific Reports. 7(1). 4105–4105. 53 indexed citations
13.
Yang, Cheng‐Wei, Hsin-Yu Chang, Hsing‐Yu Hsu, et al.. (2017). Identification of anti-viral activity of the cardenolides, Na + /K + -ATPase inhibitors, against porcine transmissible gastroenteritis virus. Toxicology and Applied Pharmacology. 332. 129–137. 23 indexed citations
14.
Lee, Shiow‐Ju, et al.. (2016). Cytotoxic cardenolides and sesquiterpenoids from the fruits of Reevesia formosana. Phytochemistry. 130. 282–290. 12 indexed citations
15.
Yang, Cheng‐Wei, Yue‐Zhi Lee, Ruey‐Bing Yang, et al.. (2015). Tylophorine compounds exert anti‐cancer activity by targeting a ribonucleoprotein complex containing caprin‐1 and c‐Myc mRNA. The FASEB Journal. 29(S1). 1 indexed citations
16.
Lee, Yue‐Zhi, Cheng‐Wei Yang, Hsin-Yu Chang, et al.. (2014). Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells. Oncotarget. 5(15). 6087–6101. 62 indexed citations
17.
Chang, Hsun‐Shuo, Michael Y. Chiang, Hsing‐Yu Hsu, et al.. (2013). Cytotoxic cardenolide glycosides from the root of Reevesia formosana. Phytochemistry. 87. 86–95. 15 indexed citations
18.
Yang, Cheng‐Wei, Yue‐Zhi Lee, Hsing‐Yu Hsu, et al.. (2013). c-Jun-mediated anticancer mechanisms of tylophorine. Carcinogenesis. 34(6). 1304–1314. 45 indexed citations
19.
Lee, Yue‐Zhi, Cheng‐Wei Yang, Hsing‐Yu Hsu, et al.. (2011). Isolation and Biological Activities of Phenanthroindolizidine and Septicine Alkaloids from the FormosanTylophora ovata. Planta Medica. 77(17). 1932–1938. 30 indexed citations
20.
Lu, Yi‐Chun, et al.. (2008). Bacteria detection utilizing electrical conductivity. Biosensors and Bioelectronics. 23(12). 1856–1861. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaohui Meng Breakdown of academic impact, for papers by Shabnam Malik Breakdown of academic impact, for papers by Vikash Singh Breakdown of academic impact, for papers by Olga I. Kiseleva Breakdown of academic impact, for papers by Mohadeseh Hasanpourghadi Breakdown of academic impact, for papers by Prashanth Srinivasan Breakdown of academic impact, for papers by Elaine Yue Ling Wong Breakdown of academic impact, for papers by Chunwei Cheng Breakdown of academic impact, for papers by Weifan Jiang Breakdown of academic impact, for papers by Shuna Cui
Rankless by CCL
2026